At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Double-Blind, Vehicle-Controlled, Randomized, Dose Ranging, Multiple-Site Clinical Study to Evaluate the Efficacy and Safety of Desoximetasone Topical Sprays (0.05%, 0.25%) in Patients With Moderate to Severe Plaque Psoriasis
In Brief
A Phase 2 clinical trial evaluating Desoximetasone 0.05% once daily, Desoximetasone 0.05% twice daily, and 3 other interventions for Psoriasis. Completed, enrolled 151 participants across 7 sites.
Detailed Summary
The objectives of this study are to evaluate the efficacy and safety of two dosing regimens of desoximetasone 0.05% and 0.25% topical sprays as compared to a vehicle spray in patients with moderate to severe plaque psoriasis.
Study Details
Timeline
Interventions
Desoximetasone topical spray 0.05% administered to affected area once daily for 28 days
Desoximetasone topical spray 0.05% administered to affected area twice daily for 28 days
Desoximetasone topical spray 0.25% administered to affected area once daily for 28 days
Desoximetasone topical spray 0.25% administered to affected areas twice daily for 28 days
Vehicle topical spray administered to affected areas once daily for 28 days
Vehicle topical spray administered to affected areas twice daily for 28 days